Chiron Real Estate posts Q2 net income

Chiron Real Estate

05/08/2026 22:02

Overview
US healthcare REIT's Q2 net income rose sharply from a loss a year earlier
Core FFO and FFO per share both declined year-over-year
Company advanced portfolio repositioning with first SHOP acquisitions and legacy asset sales

Outlook
Company did not provide specific financial guidance for the current or future periods in the press release

Result Drivers
SHOP ACQUISITIONS - Co completed first seniors housing operating portfolio acquisitions, adding new resident fee revenue and occupancy gains
LEGACY ASSET SALES - Sale of seven inpatient rehabilitation facilities generated substantial gain and capital for reinvestment
MODEST OUTPATIENT NOI GROWTH - Outpatient medical portfolio same-property cash NOI grew 0.8% year-over-year, impacted by prior-year one-time revenue recovery

Company press release: ID:nBw2CY88La

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Rental Revenue
 
$37.06 mln
 
Q2 Core FFO
 
$15.10 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy"
Wall Street's median 12-month price target for Chiron Real Estate Inc is $41.00, about 16.7% above its August 4 closing price of $35.12

Reuters Recommended Reads
Aug 3 - Sabra Health Care REIT reiterates 2026 guidance as senior housing NOI rises
Aug 4 - Healthpeak Properties raises 2026 outlook, authorizes $500 mln buyback
Aug 4 - PACS Group reports Q2 revenue beat on higher occupancy, raises outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)